BioSpace News Archive

Amgen (NASDAQ:AMGN) will present at the 2022 Bank of America Healthcare Conference at 12:20 p.m. ET on Wednesday, May 11, 2022.

Atara Biotherapeutics, Inc. reported the grant of an aggregate of 115,059 restricted stock units of Atara’s common stock to 13 newly hired employees and stock options to purchase an aggregate of 118,745 shares of Atara’s common stock to eight such newly hired employees.

Aurinia Pharmaceuticals Inc. announces a change to the dial-in number for the upcoming first quarter financial and operational results announcement on Tuesday, May 10, 2022.

Surface Oncology, Inc. announced that the company granted non-qualified stock options to five new employees to purchase an aggregate of 50,000 shares of the company’s common stock with a per share exercise price of $2.33, the closing price of Surface’s common stock as reported by Nasdaq on May 2, 2022.

Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, is aware that the Company has been identified by the United States Securities and Exchange Commission (“SEC”) under the Holding Foreign Companies Accountable Act of the United States (the “HFCAA”) on May 4, 2022.

BioCryst Pharmaceuticals, Inc. announced that the company will present at the following conferences:.

Akero Therapeutics, Inc. today reported first quarter financial results for the period ending March 31, 2022.

Centene Corporation announced its Missouri subsidiary, Home State Health, has been awarded the MO HealthNet Managed Care General Plan and Specialty Plan.

Spectrum Pharmaceuticals today announced it will host a conference call to discuss the first quarter 2022 financial results and provide a corporate update on Thursday, May 12, 2022 at 4:30 p.m. Eastern/1:30 p.m. Pacific.

IMV Inc. today announced that it will hold a conference call and webcast on Friday, May 13, 2022, at 8:00 a.m. ET to discuss the company’s 2022 first quarter financial and operational results.